FeesSafety
Pluang+

Democratic election sweep raises costs and delays for AI data center projects in key states.

Market News
04 Nov 2026, 18:00 WIB
Seeking Alpha
View Source
Bearish
Democratic election sweep raises costs and delays for AI data center projects in key states.

The recent Democratic election sweep in states like Texas, Georgia, and Ohio is expected to increase regulatory and political risks for AI data center developments. This shift will lead to higher power costs, fewer tax incentives, stricter permitting processes, and the need for developers to fund their own grid upgrades. While massive capital commitments will keep projects moving, the economics will worsen for grid-dependent and leveraged players, whereas large hyperscale companies can better absorb or relocate these costs. This state-level political change, rather than federal action, will shape the future cost structure for AI infrastructure buildouts.

The recent political shift affecting AI data centers comes with Pluang's Technology sector snapshot as context. Of 150 priced US Technology stocks on Pluang, 88 rose and 62 fell today. Notable movers include LYFT at USD 18.64 with a +11.79% change, CORZ at USD 12.84 down -9.87%, and APP at USD 269.71 up +9.86%, as of Nov 04, 2026 22:42 WIB.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
30 minutes ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
30 minutes ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
30 minutes ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
30 minutes ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
30 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App